CN111000109A - 一种防治便秘的合生元固体饮料及其制备方法 - Google Patents
一种防治便秘的合生元固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN111000109A CN111000109A CN202010014704.XA CN202010014704A CN111000109A CN 111000109 A CN111000109 A CN 111000109A CN 202010014704 A CN202010014704 A CN 202010014704A CN 111000109 A CN111000109 A CN 111000109A
- Authority
- CN
- China
- Prior art keywords
- parts
- freeze
- dried powder
- synbiotic
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007787 solid Substances 0.000 title claims abstract description 38
- 235000013361 beverage Nutrition 0.000 title claims abstract description 36
- 206010010774 Constipation Diseases 0.000 title claims abstract description 32
- 235000019722 synbiotics Nutrition 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title description 10
- 239000000843 powder Substances 0.000 claims abstract description 110
- 239000006041 probiotic Substances 0.000 claims abstract description 54
- 235000018291 probiotics Nutrition 0.000 claims abstract description 54
- 230000000529 probiotic effect Effects 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 32
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 26
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 21
- 239000003765 sweetening agent Substances 0.000 claims abstract description 21
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 12
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 12
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 12
- 241000894006 Bacteria Species 0.000 claims abstract description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 10
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 10
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 10
- 239000005715 Fructose Substances 0.000 claims description 9
- 229930091371 Fructose Natural products 0.000 claims description 9
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 9
- 108010038807 Oligopeptides Proteins 0.000 claims description 9
- 102000015636 Oligopeptides Human genes 0.000 claims description 9
- 244000057717 Streptococcus lactis Species 0.000 claims description 9
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 9
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 9
- 241000209140 Triticum Species 0.000 claims description 9
- 235000021307 Triticum Nutrition 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 8
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 8
- 241000186012 Bifidobacterium breve Species 0.000 claims description 8
- 241001608472 Bifidobacterium longum Species 0.000 claims description 8
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 8
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 8
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 8
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 8
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 8
- 229940041514 candida albicans extract Drugs 0.000 claims description 8
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 8
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000011812 mixed powder Substances 0.000 claims description 8
- 239000012138 yeast extract Substances 0.000 claims description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 7
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 7
- 229940013618 stevioside Drugs 0.000 claims description 7
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 7
- 235000019202 steviosides Nutrition 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229920001202 Inulin Polymers 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
- 229940029339 inulin Drugs 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 2
- 229960004998 acesulfame potassium Drugs 0.000 claims description 2
- 229930189775 mogroside Natural products 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 239000008176 lyophilized powder Substances 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 239000003053 toxin Substances 0.000 abstract description 6
- 231100000765 toxin Toxicity 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000008855 peristalsis Effects 0.000 abstract description 4
- 108010062877 Bacteriocins Proteins 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 244000052616 bacterial pathogen Species 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 238000012546 transfer Methods 0.000 abstract description 2
- 108700012359 toxins Proteins 0.000 abstract 3
- 230000002860 competitive effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010058699 Choline O-acetyltransferase Proteins 0.000 description 3
- 102100023460 Choline O-acetyltransferase Human genes 0.000 description 3
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 description 3
- 101710142059 Free fatty acid receptor 2 Proteins 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000021391 short chain fatty acids Nutrition 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 102000003964 Histone deacetylase Human genes 0.000 description 2
- 108090000353 Histone deacetylase Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 235000006286 nutrient intake Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000005216 enteric neuron Anatomy 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000350 mc(t) Anatomy 0.000 description 1
- 235000021253 non-digestible food component Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A23L33/145—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明实施例公开了一种防治便秘的合生元固体饮料，涉及食品加工技术领域，所述固体饮料包括如下重量份数的原料：益生菌冻干粉8‑16份、益生元45‑70份、甜味剂5.1‑10.2份、食用香精0.5‑1.5份、麦芽糊精5‑10份。本发明实施例一种防治便秘的合生元固体饮料通过多种益生菌联合使用，使胃肠道内的有益菌处于优势地位，通过竞争性占位排挤有害菌、抑制有害菌繁殖和分泌细菌素杀死有害菌并防止外来致病菌入侵，降解或分解毒素、有害物，促进毒素转移和排毒，从而促进胃肠道蠕动，对便秘有一定的调理作用，能提高机体免疫力。
Description
技术领域
本发明实施例涉及食品加工技术领域，具体涉及一种防治便秘的合生元固体饮料及其制备方法。
背景技术
研究发现：人体结肠中的短链脂肪酸(SCFAs)含量以及G-蛋白偶联受体-43(GPR43)和胆碱乙酰转移酶(ChAT)的表达出现异常，会导致便秘的发生，这是因为，SCFAs可调节肠动力，一是通过诱导粘膜肥大细胞和肠内分泌细胞表达的GPR43释放5-羟色胺(5-HT)；二是通过抑制组蛋白去乙酰化酶(histone deacetylase，HDAC)的活性，从而增加肠神经元表达ChAT的比率，最终促进结肠蠕动。
益生菌能够产生大量SCFAs，如丁酸、丙酸和乙酸，从而降低结肠的pH，促进结肠蠕动，降低结肠的传输时间；益生菌还可以分泌产生细菌素，可有效抑制大肠杆菌、沙门氏菌、梭菌等的生长繁殖，从而有效缓解便秘，其治疗效果是仅靠药物治疗无法达到的。
益生元作为一种膳食补充剂，通过选择性地刺激一种或几种菌落中的细菌的生长与活动，对宿主产生有益的影响，改善宿主的健康。其中不可被消化的食品成分，具有促进肠内益生菌群增殖、改善肠内菌群健康、缓解便秘、增强免疫力等作用。
随着社会的发展，现代人工作压力逐渐增大，导致生活规律被打乱，营养摄入失调等多种现象发生，引起恶性肿瘤疾病、退行性疾病和代谢性疾病发生。随着人们对于健康要求的提高，人们对保健食品的要求不断增强，通过饮食控制疾病发生，达到防患于未然，是目前特殊功能保健食品的研究方向。合生元作为新一代微生态调节剂，将益生菌和益生元联合应用，可同时发挥益生菌和益生元的生理功能，使益生菌和益生元协调作用，共同对抗疾病，维护机体的微生态平衡。相比单纯的益生菌或益生元而言，合生元具有更好的性价比，市场潜力更大。
发明内容
为此，本发明实施例提供一种防治便秘的合生元固体饮料及其制备方法，以解决现代人因为生活不规律、营养摄入失调等原因而引发恶性肿瘤疾病、退行性疾病和代谢性疾病的问题。
为了实现上述目的，本发明实施例提供如下技术方案：
根据本发明实施例的第一方面，一种防治便秘的合生元固体饮料，所述固体饮料包括如下重量份数的原料：益生菌冻干粉8-16份、益生元45-70份、甜味剂5.1-10.2份、食用香精0.5-1.5份、麦芽糊精5-10份。
进一步地，所述益生菌冻干粉选自乳双歧杆菌冻干粉、长双气杆菌冻干粉、短双歧杆菌冻干粉、两歧双歧杆菌冻干粉、副干酪乳杆菌冻干粉、植物乳杆菌冻干粉、乳酸乳球菌冻干粉、嗜热链球菌冻干粉中的一种或几种。
进一步地，所述益生元选自低聚木糖、低聚半乳糖、低聚果糖、菊粉中的一种或几种。
进一步地，所述甜味剂选自三氯蔗糖、罗汉果甜苷、安赛蜜、阿斯巴甜、木糖醇、甜菊糖苷、结晶果糖中的一种或几种。
进一步地，所述固体饮料还包括如下重量份数的原料：小麦低聚肽5-10份。
进一步地，所述固体饮料还包括如下重量份数的原料：酵母提取物0.5-1份。
进一步地，所述益生菌冻干粉由下列质量份数的冻干粉组成：乳双歧杆菌冻干粉1-2份、长双气杆菌冻干粉1-2份、短双歧杆菌冻干粉1-2份、两歧双歧杆菌冻干粉1-2份、副干酪乳杆菌冻干粉1-2份、植物乳杆菌冻干粉1-2份、乳酸乳球菌冻干粉1-2份、嗜热链球菌冻干粉1-2份；所述益生元由下列质量份数的原料组成：低聚木糖5-10份、低聚半乳糖20-30份和低聚果糖20-30份；所述甜味剂由下列质量份数的原料组成：甜菊糖苷0.1-0.2份和结晶果糖5-10份。
进一步地，所述益生菌冻干粉中益生菌活菌数≧2.5*109CFU/g。
根据本发明实施例的第二方面，上述的固体饮料的制备方法，所述制备方法包括如下步骤：
S1：称取各重量份数的原料，将除益生菌冻干粉外的各原料分别用紫外灯照射，备用；
S2：称取经紫外灯照射后的益生元、甜味剂、食用香精、麦芽糊精，用搅拌机搅拌10-15min，混合均匀，制得混合物；
S3：称取益生菌冻干粉加入到S2制备的混合物中，再一起投入三维混合机中进行混合得到混合粉体；在搅拌过程中，保持搅拌方向相同；
S4：将混合粉体进行充填包装，检验合格后出厂。
进一步地，S1中，所述紫外灯的波长为254nm，照射时间为15-30min。
本发明实施例具有如下优点：
本发明实施例一种防治便秘的合生元固体饮料由复合益生菌冻干粉、复合益生元、小麦低聚肽、酵母提取物、麦芽糊精、甜味剂和食用香精组成，其不含防腐剂，通过多种益生菌联合使用，使胃肠道内的有益菌处于优势地位，通过竞争性占位排挤有害菌、抑制有害菌繁殖和分泌细菌素杀死有害菌并防止外来致病菌入侵，降解或分解毒素、有害物，促进毒素转移和排毒，制得的固体饮料能促进胃肠道蠕动，对便秘有一定的调理作用，能提高机体免疫力。
本发明实施例一种防治便秘的合生元固体饮料中含有低聚木糖、低聚半乳糖、低聚果糖、结晶果糖等多种糖类物质，与蔗糖比较，不仅热量值低，不会导致肥胖，而且多种糖类结合使用，与单一糖类相比，降低了吸湿性，使其制得的固体饮料不易吸潮板结。其中，结晶果糖一方面起到增加甜度的作用，另一方面也有益于人体的消化吸收。
本发明实施例一种防治便秘的合生元固体饮料为铝膜袋包装，用水冲服，携带和服用方便。
本发明实施例一种防治便秘的合生元固体饮料的制备方法通过干混工艺进行调配，能有效地保证益生菌活菌数，操作简单，保质期长，可以普遍推广。
具体实施方式
以下由特定的具体实施例说明本发明的实施方式，熟悉此技术的人士可由本说明书所揭露的内容轻易地了解本发明的其他优点及功效，显然，所描述的实施例是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
一种防治便秘的合生元固体饮料，所述固体饮料包括如下重量份数的原料：益生菌冻干粉8份、益生元45份、甜味剂5.1份、食用香精0.5份、麦芽糊精5份、小麦低聚肽5份、酵母提取物0.5份；所述益生菌冻干粉中益生菌活菌数≧2.5*109CFU/g。
所述益生菌冻干粉由下列质量份数的冻干粉组成：乳双歧杆菌冻干粉1份、长双气杆菌冻干粉1份、短双歧杆菌冻干粉1份、两歧双歧杆菌冻干粉1份、副干酪乳杆菌冻干粉1份、植物乳杆菌冻干粉1份、乳酸乳球菌冻干粉1份、嗜热链球菌冻干粉1份；
所述益生元由下列质量份数的原料组成：低聚木糖5份、低聚半乳糖20份和低聚果糖20份；
所述甜味剂由下列质量份数的原料组成：甜菊糖苷0.1份和结晶果糖5份。
所述的固体饮料的制备方法包括如下步骤：
S1：称取各重量份数的原料，将除益生菌冻干粉外的各原料分别用紫外灯照射，备用；紫外灯的波长为254nm，照射时间为15-30min；
S2：称取经紫外灯照射后的益生元、甜味剂、食用香精、麦芽糊精、小麦低聚肽、酵母提取物，用搅拌机搅拌10-15min，混合均匀，制得混合物；
S3：称取益生菌冻干粉加入到S2制备的混合物中，再一起投入三维混合机中进行混合得到混合粉体；在搅拌过程中，保持搅拌方向相同；
S4：将混合粉体按4g/袋进行充填包装，检验存储。检验以每一批次为检验对象，按抽样规则进行随机抽样，进行出厂检验，检验项目按该产品出厂检验项目进行检验，检验合格后，附上质量合格证明待出厂，然后将检验合格的成品，根据不同规格、不同批号分别堆放于阴凉、通风、干燥、无毒、无异味、防鼠的成品仓库内。
实施例2
一种防治便秘的合生元固体饮料，所述固体饮料包括如下重量份数的原料：益生菌冻干粉16份、益生元70份、甜味剂10.2份、食用香精1.5份、麦芽糊精10份、小麦低聚肽10份、酵母提取物1份；所述益生菌冻干粉中益生菌活菌数≧2.5*109CFU/g。
所述益生菌冻干粉由下列质量份数的冻干粉组成：乳双歧杆菌冻干粉2份、长双气杆菌冻干粉2份、短双歧杆菌冻干粉2份、两歧双歧杆菌冻干粉2份、副干酪乳杆菌冻干粉2份、植物乳杆菌冻干粉2份、乳酸乳球菌冻干粉2份、嗜热链球菌冻干粉2份；
所述益生元由下列质量份数的原料组成：低聚木糖10份、低聚半乳糖30份和低聚果糖30份；
所述甜味剂由下列质量份数的原料组成：甜菊糖苷0.2份和结晶果糖10份。
所述的固体饮料的制备方法同实施例1。
实施例3
一种防治便秘的合生元固体饮料，所述固体饮料包括如下重量份数的原料：益生菌冻干粉12份、益生元57.5份、甜味剂8份、食用香精1份、麦芽糊精7.5份、小麦低聚肽7.5份、酵母提取物0.75份；所述益生菌冻干粉中益生菌活菌数≧2.5*109CFU/g。
所述益生菌冻干粉由下列质量份数的冻干粉组成：乳双歧杆菌冻干粉1.5份、长双气杆菌冻干粉1.5份、短双歧杆菌冻干粉1.5份、两歧双歧杆菌冻干粉1.5份、副干酪乳杆菌冻干粉1.5份、植物乳杆菌冻干粉1.5份、乳酸乳球菌冻干粉1.5份、嗜热链球菌冻干粉1.5份；
所述益生元由下列质量份数的原料组成：低聚木糖7.5份、低聚半乳糖25份和低聚果糖25份；
所述甜味剂由下列质量份数的原料组成：甜菊糖苷0.2份和结晶果糖7.8份。
所述的固体饮料的制备方法同实施例1。
实施例4
一种防治便秘的合生元固体饮料，所述固体饮料包括如下重量份数的原料：益生菌冻干粉10份、益生元50份、甜味剂7份、食用香精0.8份、麦芽糊精6.5份、小麦低聚肽6份、酵母提取物0.5份；所述益生菌冻干粉中益生菌活菌数≧2.5*109CFU/g。
所述益生菌冻干粉由下列质量份数的冻干粉组成：两歧双歧杆菌冻干粉2.5份、副干酪乳杆菌冻干粉2.5份、乳酸乳球菌冻干粉2.5份、嗜热链球菌冻干粉2.5份；
所述益生元由下列质量份数的原料组成：菊粉22.5份、低聚半乳糖20份和低聚木糖7.5份；
所述甜味剂由下列质量份数的原料组成：阿斯巴甜0.2份和木糖醇6.8份。
所述的固体饮料的制备方法同实施例1。
实施例5
一种防治便秘的合生元固体饮料，所述固体饮料包括如下重量份数的原料：益生菌冻干粉14份、益生元62份、甜味剂9.1份、食用香精1.2份、麦芽糊精9份、小麦低聚肽9份、酵母提取物0.8份；所述益生菌冻干粉中益生菌活菌数≧2.5*109CFU/g。
所述益生菌冻干粉由下列质量份数的冻干粉组成：乳双歧杆菌冻干粉2份、长双气杆菌冻干粉2份、短双歧杆菌冻干粉2份、副干酪乳杆菌冻干粉2份、植物乳杆菌冻干粉2份、乳酸乳球菌冻干粉2份、嗜热链球菌冻干粉2份；
所述益生元由下列质量份数的原料组成：菊粉32份、低聚半乳糖30份；
所述甜味剂由下列质量份数的原料组成：安赛蜜0.1份和木糖醇9份。
所述的固体饮料的制备方法同实施例1。
本发明一种防治便秘的合生元固体饮料口感佳，具有保健功能，对便秘有明显的调理作用，能提高机体免疫力。本发明的固体饮料的保健效果是辅助性的，务必不能作为单独的防治便秘的药物使用。
虽然，上文中已经用一般性说明及具体实施例对本发明作了详尽的描述，但在本发明基础上，可以对之作一些修改或改进，这对本领域技术人员而言是显而易见的。因此，在不偏离本发明精神的基础上所做的这些修改或改进，均属于本发明要求保护的范围。
Claims (10)
1.一种防治便秘的合生元固体饮料，其特征在于，所述固体饮料包括如下重量份数的原料：益生菌冻干粉8-16份、益生元45-70份、甜味剂5.1-10.2份、食用香精0.5-1.5份、麦芽糊精5-10份。
2.如权利要求1所述的一种防治便秘的合生元固体饮料，其特征在于，所述益生菌冻干粉选自乳双歧杆菌冻干粉、长双气杆菌冻干粉、短双歧杆菌冻干粉、两歧双歧杆菌冻干粉、副干酪乳杆菌冻干粉、植物乳杆菌冻干粉、乳酸乳球菌冻干粉、嗜热链球菌冻干粉中的一种或几种。
3.如权利要求1所述的一种防治便秘的合生元固体饮料，其特征在于，所述益生元选自低聚木糖、低聚半乳糖、低聚果糖、菊粉中的一种或几种。
4.如权利要求1所述的一种防治便秘的合生元固体饮料，其特征在于，所述甜味剂选自三氯蔗糖、罗汉果甜苷、安赛蜜、阿斯巴甜、木糖醇、甜菊糖苷、结晶果糖中的一种或几种。
5.如权利要求1所述的一种防治便秘的合生元固体饮料，其特征在于，所述固体饮料还包括如下重量份数的原料：小麦低聚肽5-10份。
6.如权利要求1所述的一种防治便秘的合生元固体饮料，其特征在于，所述固体饮料还包括如下重量份数的原料：酵母提取物0.5-1份。
7.如权利要求2所述的一种防治便秘的合生元固体饮料，其特征在于，所述益生菌冻干粉由下列质量份数的冻干粉组成：乳双歧杆菌冻干粉1-2份、长双气杆菌冻干粉1-2份、短双歧杆菌冻干粉1-2份、两歧双歧杆菌冻干粉1-2份、副干酪乳杆菌冻干粉1-2份、植物乳杆菌冻干粉1-2份、乳酸乳球菌冻干粉1-2份、嗜热链球菌冻干粉1-2份；所述益生元由下列质量份数的原料组成：低聚木糖5-10份、低聚半乳糖20-30份和低聚果糖20-30份；所述甜味剂由下列质量份数的原料组成：甜菊糖苷0.1-0.2份和结晶果糖5-10份。
8.如权利要求1所述的一种防治便秘的合生元固体饮料，其特征在于，所述益生菌冻干粉中益生菌活菌数≧2.5*109CFU/g。
9.如权利要求1-8任一项所述的固体饮料的制备方法，其特征在于，所述制备方法包括如下步骤：
S1：称取各重量份数的原料，将除益生菌冻干粉外的各原料分别用紫外灯照射，备用；
S2：称取经紫外灯照射后的益生元、甜味剂、食用香精、麦芽糊精，用搅拌机搅拌10-15min，混合均匀，制得混合物；
S3：称取益生菌冻干粉加入到S2制备的混合物中，再一起投入三维混合机中进行混合得到混合粉体；在搅拌过程中，保持搅拌方向相同；
S4：将混合粉体进行充填包装，检验合格后出厂。
10.如权利要求9所述的固体饮料的制备方法，其特征在于，S1中，所述紫外灯的波长为254nm，照射时间为15-30min。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010014704.XA CN111000109A (zh) | 2020-01-07 | 2020-01-07 | 一种防治便秘的合生元固体饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010014704.XA CN111000109A (zh) | 2020-01-07 | 2020-01-07 | 一种防治便秘的合生元固体饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111000109A true CN111000109A (zh) | 2020-04-14 |
Family
ID=70120615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010014704.XA Pending CN111000109A (zh) | 2020-01-07 | 2020-01-07 | 一种防治便秘的合生元固体饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111000109A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111743998A (zh) * | 2020-06-04 | 2020-10-09 | 中通美雅生命健康(深圳)有限公司 | 用于辅助治疗肠炎组合物及其制备方法 |
| CN112155056A (zh) * | 2020-09-28 | 2021-01-01 | 北京三元食品股份有限公司 | 一种调节肠道的酸奶及其制备方法和应用 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104397188A (zh) * | 2014-12-04 | 2015-03-11 | 保龄宝生物股份有限公司 | 一种含益生元的低热量固体奶茶及其制备方法 |
| CN109042893A (zh) * | 2018-10-23 | 2018-12-21 | 汉臣氏（沈阳）儿童制品有限公司 | 一种益生菌植物蛋白粉固体饮料 |
| CN109222105A (zh) * | 2018-07-20 | 2019-01-18 | 徐谓 | 一种全消化道改善的复合营养食品及其制备方法 |
| CN109619596A (zh) * | 2019-01-28 | 2019-04-16 | 江西美好时光生物科技有限公司 | 一种调理便秘的益生菌粉及其制备方法 |
| CN109662228A (zh) * | 2018-12-04 | 2019-04-23 | 广州金叶健康科技有限公司 | 一种具有保健功能的益生菌固体饮料及其制备方法 |
| CN109744357A (zh) * | 2017-11-05 | 2019-05-14 | 达威控股有限公司 | 一种对人体肠道有保健功能的糖及其制备方法 |
| CN111296854A (zh) * | 2020-03-16 | 2020-06-19 | 上海拜姿实业有限公司 | 一种综合改善胃部和肠道健康的产品及其制备方法和应用 |
-
2020
- 2020-01-07 CN CN202010014704.XA patent/CN111000109A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104397188A (zh) * | 2014-12-04 | 2015-03-11 | 保龄宝生物股份有限公司 | 一种含益生元的低热量固体奶茶及其制备方法 |
| CN109744357A (zh) * | 2017-11-05 | 2019-05-14 | 达威控股有限公司 | 一种对人体肠道有保健功能的糖及其制备方法 |
| CN109222105A (zh) * | 2018-07-20 | 2019-01-18 | 徐谓 | 一种全消化道改善的复合营养食品及其制备方法 |
| CN109042893A (zh) * | 2018-10-23 | 2018-12-21 | 汉臣氏（沈阳）儿童制品有限公司 | 一种益生菌植物蛋白粉固体饮料 |
| CN109662228A (zh) * | 2018-12-04 | 2019-04-23 | 广州金叶健康科技有限公司 | 一种具有保健功能的益生菌固体饮料及其制备方法 |
| CN109619596A (zh) * | 2019-01-28 | 2019-04-16 | 江西美好时光生物科技有限公司 | 一种调理便秘的益生菌粉及其制备方法 |
| CN111296854A (zh) * | 2020-03-16 | 2020-06-19 | 上海拜姿实业有限公司 | 一种综合改善胃部和肠道健康的产品及其制备方法和应用 |
Non-Patent Citations (2)
| Title |
|---|
| 中国农村技术开发中心等: "《舌尖上的新食品》", 31 March 2016, 中国轻工业出版社 * |
| 吉鹤立: "《中国食品添加剂及配料使用手册》", 30 June 2016, 中国质检出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111743998A (zh) * | 2020-06-04 | 2020-10-09 | 中通美雅生命健康(深圳)有限公司 | 用于辅助治疗肠炎组合物及其制备方法 |
| CN112155056A (zh) * | 2020-09-28 | 2021-01-01 | 北京三元食品股份有限公司 | 一种调节肠道的酸奶及其制备方法和应用 |
| CN112155056B (zh) * | 2020-09-28 | 2022-03-04 | 北京三元食品股份有限公司 | 一种调节肠道的酸奶及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3264923B1 (en) | Compositions for use in the prevention or treatment of gastrointestinal infections in infants or young children | |
| Sharma et al. | Probiotics: a comprehensive approach toward health foods | |
| EP1481682B1 (en) | Preparation that contains oligosaccharides and probiotics | |
| CN106954847A (zh) | 具有润肠通便功能的酵素益生菌组合物、应用及加工制剂 | |
| EP1513541B1 (en) | Method for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract | |
| EP2308498A1 (en) | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life | |
| BRPI0809622A2 (pt) | Probióticos para aperfeiçoamento de microbiota de intestino | |
| CN111671079A (zh) | 一种复合益生菌粉组合物及其制备方法 | |
| CN111000109A (zh) | 一种防治便秘的合生元固体饮料及其制备方法 | |
| CN114698849A (zh) | 一种益生菌组合物及其制备方法和应用 | |
| CN111296711A (zh) | 一种益生菌固体饮料及其制备方法 | |
| CN112741315A (zh) | 水果益生菌膳食纤维粉固体饮料及其制备方法 | |
| CN112617207A (zh) | 一种含有补液盐和益生菌的组合物 | |
| CN111657422A (zh) | 一种预糊化焦米粉组合物及其制备方法 | |
| CN112971066A (zh) | 一种益生菌果泥 | |
| CN115066188A (zh) | 组合物 | |
| Ribaldone et al. | Modulation of the gut microbiota: Opportunities and regulatory aspects | |
| US20180185397A1 (en) | Isomalto-Oligosaccharide Prebiotic Formulations | |
| CN113575959A (zh) | 一种能够抑制有害菌的益生菌组合物 | |
| KR20140108822A (ko) | 과민성대장증후군 개선용 조성물 | |
| KR20220058176A (ko) | 장내 균총 개선용 프리바이오틱스 조성물 | |
| CN111264739A (zh) | 一种益生菌固体饮料及其制备方法 | |
| Chikkamath et al. | The role of probiotics, prebiotics and synbiotic on human health and disease-A review | |
| TWI815258B (zh) | 益生元組合物及木豆屬組合物用於調整腸胃道菌相之用途 | |
| CN111743998A (zh) | 用于辅助治疗肠炎组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200414 |
|
| RJ01 | Rejection of invention patent application after publication |